Αρχειοθήκη ιστολογίου

Σάββατο 9 Σεπτεμβρίου 2017

Regorafenib versus lomustine for relapsed glioblastoma

Dr Lombardi talks with ecancer at the ESMO 2017 Congress about the randomised, phase II REGOMA trial evaluating regorafenib versus lomustine in relapsed glioblastoma patients. He outlines that the primary endpoint for the study, overall survival, was...

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2gRBAY5
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader